The Government has made amendments in the export policy and restricted export of specified APIs (Active Pharmaceutical Ingredients) and formulations made from these APIs.

A notification issued by Directorate General of Foreign Trade, M/o Commerce and Industry says that the restrictions will come into immediate effect and until further orders.  The notification covers following APIs and formulations made from these APIs:

1. Paracetamol, 2. Tinidazole, 3. Metronidazole, 4. Acyclovir, 5. Vitamin B1, 6. Vitamin B6, 7. Vitamin B12, 8. Progesterone, 9. Chloramphenicol, 10. Erythromycin Salts, 11. Neomycin, 12. Clindamycin Salts and 13. Ornidazole.

Government of India
Ministry of Commerce & Industry
Department of Commerce
Directorate General of Foreign Trade
Udyog Bhavan
New Delhi

Notification No. 50/2015-2020-DGFT

New Delhi, Dated: 03rd March, 2020

Subject: Amendment in Export Policy of APIs and formulations made from these APIs

S.O. (E) In exercise of powers conferred by Section 3 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended. read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2015-20, the Central Government hereby makes amendment, with immediate effect in Chapter 29(Organic Chemicals) and Chapter 30 (Pharmaceutical) of the Schedule 2 of the ITC (HS) Export Policy 2018, by inclusion of items, as indicated in the Table below:

S.No ITC HS Codes Description Present Policy Revised Policy
146 A 29222933 Paracetamol Free Restricted
146 B 29332910 Tinidazole
146 C 29332920 Metronidazole
146 D 29335990 Acyclovir
146E 29362210 Vitamin B1
146 F 29362500 Vitamin B6
146 G 29362610 Vitamin B12
146 H 29372300 Progesterone
146 1 29414000 Chloramphenicol
146 J 29415000 Erythromycin Salts
146 K 29419050 Neomycin
146 L 29419090 Clindamycin Salts
146 M 29420090 Ornidazole
156 A 30042050 Formulations made of  Chloramphenicol
156 B 30042061 Formulations made of  Erythromycin Salts
156 C 30042095 Formulations made or Clindamycin Salts
156 D 30043919 Formulations made of  Progesterone
156 E 30045032 Formulations made of Vitamin B1
156 F 30045032 Formulations made of Vitamin B12
156G 30045039 Formulations made of Vitamin B6
156H 30049015 Formulations made of Neomycin
156I 30049021 Formulations made of Ornidazole
156J 30049022 Formulations made of Metronidazole
156K 30049023 Formulations made of Tinidazole
156L 30049099 Formulations made of Acyclovir
156M 30049099 Formulations made of Paracetamol

2. Effect of this Notification:

Export of specified APIs (Active Pharmaceutical Ingredients) and formulations made from these APIs under the ITC HS Codes mentioned against each is hereby ‘restricted’, with immediate effect and till further orders.

(Amit Yadav)
Director General of Foreign Trade
Ex-Officio Additional Secretary, Government of India
E-mail: [email protected]

(Issued from File No. 01/91/180/24/AM20/EC)

More Under DGFT

Leave a Comment

Your email address will not be published. Required fields are marked *

Search Posts by Date

May 2021